Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Tetra bio pharma new video

<< Previous

Bullboard Posts

Next >>

Comment by Golddetectoron Mar 27, 2022 8:54am

153 Views

Post# 34549533

RE:RE:Tetra bio pharma new video

That is a good summary but One thing to add is tetra targeting to market QIXLEEF based on phaseII results. If you read the last nr they are planning to do so with plenitude data support. If this gets approved by FDA it will mean that marketing can start as early as next year. This opioid alternative is going to be a big deal there is no way that big pharma will let this go. It will be taken by one of these big boys. Last deal was for 6 or 7 billions for a drug with way less applications. I wonder how much this will worth?

<< Previous

Bullboard Posts

Next >>

Canada Nickel unveils second of seven resources planned by mid-2025